×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Xerosis Market

ID: MRFR/Pharma/18551-HCR
100 Pages
Rahul Gotadki
February 2026

US Xerosis Market Research Report By Treatment (emollients, moisturizer, humidifier, oils, others), By Causes (eczema, psoriasis, diabetes, hypothyroidism, aging, others) and By End Users (hospitals, dermatology clinics, home care) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Xerosis Market Infographic
Purchase Options

US Xerosis Market Summary

As per Market Research Future analysis, the US xerosis market Size was estimated at 714.0 USD Million in 2024. The US xerosis market is projected to grow from 742.63 USD Million in 2025 to 1100.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.0% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The US xerosis market is experiencing a robust growth trajectory driven by evolving consumer preferences and increasing awareness of skin health.

  • The demand for moisturizers is rising as consumers seek effective solutions for xerosis.
  • There is a notable shift towards natural ingredients in skincare formulations, reflecting changing consumer values.
  • Technological advancements in product formulations are enhancing the efficacy of xerosis treatments.
  • The increasing prevalence of xerosis and heightened awareness of skin health are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 714.0 (USD Million)
2035 Market Size 1100.0 (USD Million)
CAGR (2025 - 2035) 4.01%

Major Players

Johnson & Johnson (US), Bayer AG (DE), Galderma S.A. (CH), Eucerin (DE), CeraVe (US), Neutrogena (US), Aveeno (US), La Roche-Posay (FR), Avene (FR)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

US Xerosis Market Trends

The xerosis market is currently experiencing notable growth, driven by an increasing prevalence of dry skin conditions among various demographics. Factors such as environmental changes, lifestyle choices, and an aging population contribute to the rising demand for effective treatments and preventive measures. As awareness of skin health continues to expand, consumers are seeking products that not only alleviate symptoms but also promote overall skin hydration and wellness. This trend is further supported by advancements in dermatological research, leading to the development of innovative formulations that cater to diverse skin types and conditions. In addition, the xerosis market is witnessing a shift towards natural and organic products, as consumers become more conscious of the ingredients in their skincare routines. This inclination towards clean beauty is prompting manufacturers to reformulate existing products and introduce new lines that emphasize sustainability and safety. The regulatory landscape is also evolving, with increased scrutiny on product claims and ingredient transparency, which may influence consumer purchasing decisions. Overall, the xerosis market appears poised for continued expansion, reflecting broader trends in health and wellness, as well as a growing emphasis on personalized skincare solutions.

Rising Demand for Moisturizers

There is a noticeable increase in the demand for moisturizers specifically designed for xerosis. Consumers are actively seeking products that provide long-lasting hydration and relief from dry skin symptoms. This trend is likely influenced by heightened awareness of skin health and the importance of maintaining skin moisture.

Shift Towards Natural Ingredients

A significant trend within the xerosis market is the growing preference for products containing natural and organic ingredients. Consumers are becoming more discerning about the formulations they choose, often favoring those that are free from synthetic additives. This shift may reflect a broader movement towards clean beauty and sustainability.

Technological Advancements in Formulations

Innovations in formulation technology are shaping the xerosis market. Manufacturers are increasingly investing in research and development to create advanced products that effectively address dry skin issues. These advancements may include the incorporation of new active ingredients and delivery systems that enhance product efficacy.

US Xerosis Market Drivers

Awareness of Skin Health

There is a notable increase in consumer awareness regarding skin health, which significantly impacts the xerosis market. Educational campaigns and health initiatives have led to a better understanding of skin conditions, including xerosis. As individuals become more informed about the importance of skin hydration and the potential complications of untreated dry skin, they are more inclined to seek out effective products. Market data suggests that the demand for moisturizers and hydrating treatments has surged by approximately 25% over the past few years. This heightened awareness not only drives sales but also encourages manufacturers to innovate and improve their product offerings, thereby enhancing the overall competitiveness of the xerosis market.

Growth of E-commerce Platforms

The expansion of e-commerce platforms has transformed the way consumers access products in the xerosis market. Online shopping provides convenience and a wider selection of products, allowing consumers to easily compare options and read reviews. Recent statistics indicate that online sales of skincare products have increased by over 40% in the past year alone. This shift towards digital purchasing is particularly beneficial for niche products targeting xerosis, as consumers can find specialized solutions that may not be available in traditional retail settings. Consequently, the growth of e-commerce is likely to play a crucial role in driving the overall sales and visibility of products within the xerosis market.

Increasing Prevalence of Xerosis

The rising incidence of xerosis in the US population is a primary driver for the xerosis market. Factors such as aging, environmental conditions, and lifestyle choices contribute to this trend. According to recent data, approximately 30% of adults in the US experience some form of dry skin, particularly during winter months. This growing prevalence necessitates a wider range of treatment options, thereby expanding the market. The xerosis market is likely to see increased demand for specialized products, including moisturizers and topical treatments, as consumers seek effective solutions to manage their skin condition. Furthermore, the aging population, which is projected to reach 73 million by 2030, will likely exacerbate the demand for xerosis-related products, indicating a robust growth trajectory for the industry.

Rising Interest in Preventive Skincare

The trend towards preventive skincare is gaining traction among consumers, which is a significant driver for the xerosis market. Individuals are increasingly adopting proactive measures to maintain skin health, rather than solely addressing issues as they arise. This shift in mindset has led to a growing demand for moisturizers and hydrating products designed for daily use. Market analysis indicates that preventive skincare products have seen a growth rate of approximately 20% in recent years. As consumers prioritize long-term skin health, the xerosis market is likely to experience sustained growth, with an emphasis on products that promote hydration and skin barrier function.

Regulatory Support for Dermatological Products

Regulatory bodies in the US are increasingly supportive of dermatological products, which positively influences the xerosis market. The Food and Drug Administration (FDA) has streamlined approval processes for certain topical treatments, encouraging innovation and the introduction of new products. This regulatory environment fosters competition among manufacturers, leading to a broader range of effective solutions for consumers suffering from xerosis. Additionally, the approval of new ingredients and formulations can enhance product efficacy, further driving consumer interest. As a result, the xerosis market is likely to benefit from a more dynamic product landscape, with an increasing number of options available to address various degrees of skin dryness.

Market Segment Insights

By Severity Level: Moderate (Largest) vs. Severe (Fastest-Growing)

In the US xerosis market, the distribution of severity levels reveals that the Moderate segment holds the largest share, appealing to a vast demographic in need of skin hydration solutions. Mild cases also contribute significantly, but their overall market presence is overshadowed by the Moderate severity. Conversely, the Severe and Very Severe segments, although smaller, show a noteworthy increase in consumer demand as awareness about severe skin conditions rises. Growth trends within the severity levels are largely driven by an increase in diagnostic criteria and greater patient education. Consumers are becoming more informed about skin conditions, leading to earlier diagnosis and treatment, particularly in the Severe segment, which is currently the fastest-growing area. This trend indicates a shift towards more aggressive treatments and specialized skincare products aimed at severe manifestations of xerosis, positioning them as essential for meeting consumer needs.

Moderate (Dominant) vs. Severe (Emerging)

The Moderate segment is recognized as the dominant category within the US xerosis market, primarily serving individuals with manageable dry skin conditions. This segment benefits from a broad consumer base, as the characteristics of moderate xerosis often necessitate regular moisturizing and therapeutic products that are widely available. In contrast, the Severe segment is emerging rapidly, indicating a heightened consumer focus on more intensive treatment options. This growing awareness is leading to increased market activity including new product launches designed specifically for severe cases. The Severe segment is characterized by a need for prescription-grade solutions, and the market dynamics are shifting to cater to the heightened demand for effective care innovations that address chronic and painful skin conditions.

By Treatment Type: Topical Treatments (Largest) vs. Advanced Therapies (Fastest-Growing)

In the US xerosis market, topical treatments command the largest share, preferred for their efficacy and ease of application. These products typically include creams, lotions, and ointments that provide moisture directly to the skin, helping to relieve dryness effectively. In contrast, advanced therapies, although currently a smaller segment, are rapidly growing as they include cutting-edge treatments such as biologics and innovative moisturizers that address xerosis at a deeper level, appealing to consumers seeking more comprehensive solutions. The growth in the advanced therapies segment is driven by increasing awareness of dermatological conditions and a rising preference for products that utilize scientific advancements. Additionally, the demand for personalized skincare solutions is spurring innovation within this segment, positioning it as the fastest-growing category. Factors such as accelerated research and development in dermatology further support the expansion of advanced therapies, with consumers increasingly willing to invest in more sophisticated alternatives to traditional treatments.

Topical Treatments (Dominant) vs. Oral Medications (Emerging)

Topical treatments are the dominant force in the US xerosis market, favored for their targeted application and direct impact on the skin's moisture levels. Their popularity stems from the wide range of formulations available, including those with added active ingredients that enhance hydration. Conversely, oral medications have emerged as an alternative by offering systemic relief from xerosis, appealing to consumers who prefer convenient ingestion over topical application. This segment is gaining traction due to the increasing recognition of the importance of internal hydration and potential therapeutic benefits beyond surface-level treatment, particularly in more severe cases of xerosis.

By End User: Hospitals (Largest) vs. Home Care (Fastest-Growing)

In the US xerosis market, the segment distribution reveals that hospitals hold the largest market share, primarily due to the high demand for dermatological treatments in these settings. Clinics and pharmacies also play significant roles, but their shares are notably lower compared to hospitals. Home care is gaining traction as more individuals seek convenient and accessible treatments at home, reflecting a shift in consumer preference towards self-care solutions. Growth trends in this segment are largely driven by the increasing prevalence of skin disorders, aging populations, and a growing awareness about skin health. Hospitals remain a dominant force, yet the home care segment is emerging rapidly, fueled by advances in telehealth and online consultations that enable patients to effectively manage xerosis from their homes. This shift is expected to continue as more patients prioritize personalized care and convenience over traditional treatment pathways.

Hospitals: Dominant vs. Home Care: Emerging

Hospitals serve as the cornerstone of the US xerosis market, equipped with advanced medical facilities and specialists that cater extensively to patients with skin ailments. The comprehensive treatment options available in hospitals include prescription therapies and outpatient services, making them a preferred choice for many. Conversely, the home care segment is rapidly emerging as a viable alternative, catering to the increasing demand for self-managed care solutions. This segment thrives on the growing availability of over-the-counter treatments and telemedicine services, allowing patients to effectively address their xerosis conditions from the comfort of their homes. Both segments highlight the evolving healthcare landscape, where traditional and modern approaches coexist to meet diverse patient needs.

By Formulation Type: Creams (Largest) vs. Lotions (Fastest-Growing)

In the US xerosis market, the formulation type segment is diverse, consisting primarily of creams, lotions, ointments, and gels. Currently, creams hold the largest share due to their rich consistency and effectiveness in providing moisture relief. Lotions, while trailing in overall market share, have been gaining ground rapidly, reflecting a shift in consumer preferences toward lighter formulations that are easier to apply and absorb quickly. The growth trends within this segment are influenced by rising awareness of skin health and the prevalence of xerosis among various demographics. The demand for lotions is particularly boosted by targeted marketing towards younger consumers who favor products with lightweight formulations. Additionally, innovations in formulation technology are propelling the development of products that cater to specific skin concerns, further driving growth across all categories.

Creams: Dominant vs. Lotions: Emerging

Creams are widely regarded as the dominant formulation type in the US xerosis market, primarily due to their strong moisturizing properties and ability to create a protective barrier on the skin. This makes them particularly effective for treating severe dryness conditions. However, lotions are emerging rapidly as a popular choice, especially among consumers looking for convenient and easily applicable options. They are often perceived as more comfortable for daily use and are particularly appealing to younger demographics. As both segment values evolve, brands are focusing on enhancing the quality and efficacy of their products, driving further differentiation within the market.

Get more detailed insights about US Xerosis Market

Key Players and Competitive Insights

The xerosis market exhibits a dynamic competitive landscape characterized by a blend of innovation, strategic partnerships, and a focus on consumer-centric solutions. Key players such as Johnson & Johnson (US), Galderma S.A. (CH), and CeraVe (US) are actively shaping the market through their distinct operational strategies. Johnson & Johnson (US) emphasizes innovation in product formulations, particularly in developing advanced moisturizers that cater to diverse skin types. Galderma S.A. (CH) focuses on dermatological expertise, leveraging its strong research capabilities to introduce targeted treatments for xerosis. Meanwhile, CeraVe (US) has carved a niche by promoting its dermatologist-developed products, which resonate well with health-conscious consumers. Collectively, these strategies foster a competitive environment that prioritizes quality and efficacy, thereby driving market growth.In terms of business tactics, companies are increasingly localizing manufacturing to enhance supply chain efficiency and reduce costs. This approach not only streamlines operations but also allows for quicker response times to market demands. The competitive structure of the xerosis market appears moderately fragmented, with several players vying for market share. However, the influence of major companies remains substantial, as they set benchmarks for product quality and innovation that smaller firms strive to meet.

In October Johnson & Johnson (US) announced the launch of a new line of hydrating creams specifically formulated for sensitive skin. This strategic move is likely to enhance their market presence by addressing a growing consumer demand for specialized skincare solutions. The introduction of these products aligns with the company's commitment to innovation and could potentially capture a significant share of the sensitive skin segment within the xerosis market.

In September Galderma S.A. (CH) expanded its product portfolio by acquiring a niche brand known for its natural ingredients aimed at treating dry skin conditions. This acquisition not only diversifies Galderma's offerings but also strengthens its position in the growing market for natural and organic skincare products. The strategic importance of this move lies in its potential to attract environmentally conscious consumers, thereby enhancing brand loyalty and market penetration.

In August CeraVe (US) launched a digital campaign aimed at educating consumers about the importance of moisturizing for xerosis management. This initiative reflects a broader trend towards digital transformation in the skincare industry, where companies leverage online platforms to engage with consumers directly. By positioning itself as a thought leader in skincare education, CeraVe is likely to enhance its brand reputation and foster deeper connections with its customer base.

As of November the xerosis market is increasingly defined by trends such as digitalization, sustainability, and the integration of artificial intelligence in product development. Strategic alliances among companies are becoming more prevalent, facilitating knowledge sharing and resource optimization. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition underscores the importance of delivering high-quality, effective solutions that meet the evolving needs of consumers.

Key Companies in the US Xerosis Market include

Industry Developments

The US Xerosis Market has seen notable recent developments and growth dynamics, particularly with companies such as Novartis, Eucerin, GlaxoSmithKline, and Eli Lilly making headlines. Procter and Gamble and Aveeno announced new product launches targeting xerosis, while CeraVe, Dermavant Sciences, and Humboldt Therapeutics continued to expand their therapeutic offerings.

In a significant merger, Allergan finalized a strategic acquisition of a skin care line in June 2023, reflecting consolidation trends in the market. Meanwhile, Amgen and Johnson and Johnson reported advancements in their xerosis-related treatments, contributing to an increasing market valuation. The most recent data indicates a surge in the demand for moisturizers and topical treatments, indicating a sustained interest in xerosis solutions.

Additionally, regulatory changes in August 2023 have improved the approval processes for new dermatological treatments, benefiting companies like Bayer and Mylan. Over the past couple of years, the market has evolved significantly as companies invest in Research and Development to innovate solutions for xerosis, indicating a vibrant and competitive landscape focused on improving patient care in the US.

Future Outlook

US Xerosis Market Future Outlook

The Xerosis Market is projected to grow at 4.01% CAGR from 2025 to 2035, driven by increasing awareness, innovative treatments, and rising prevalence of skin conditions.

New opportunities lie in:

  • Development of targeted topical formulations for specific xerosis types.
  • Expansion of telehealth services for remote patient consultations.
  • Investment in AI-driven diagnostic tools for early xerosis detection.

By 2035, the xerosis market is expected to achieve substantial growth and innovation.

Market Segmentation

US Xerosis Market End User Outlook

  • Hospitals
  • Clinics
  • Home Care
  • Pharmacies

US Xerosis Market Severity Level Outlook

  • Mild
  • Moderate
  • Severe
  • Very Severe

US Xerosis Market Treatment Type Outlook

  • Topical Treatments
  • Oral Medications
  • Advanced Therapies
  • Home Remedies

US Xerosis Market Formulation Type Outlook

  • Creams
  • Lotions
  • Ointments
  • Gels

Report Scope

MARKET SIZE 2024 714.0(USD Million)
MARKET SIZE 2025 742.63(USD Million)
MARKET SIZE 2035 1100.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 4.01% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Johnson & Johnson (US), Bayer AG (DE), Galderma S.A. (CH), Eucerin (DE), CeraVe (US), Neutrogena (US), Aveeno (US), La Roche-Posay (FR), Avene (FR)
Segments Covered Severity Level, Treatment Type, End User, Formulation Type
Key Market Opportunities Emerging natural ingredients in skincare formulations address increasing consumer demand for xerosis treatment.
Key Market Dynamics Rising consumer awareness drives demand for innovative xerosis treatments amid evolving regulatory standards.
Countries Covered US
Leave a Comment

FAQs

What is the expected market size of the US Xerosis Market in 2024?

The US Xerosis Market is expected to be valued at 1.65 billion USD in 2024.

What is the projected market size of the US Xerosis Market by 2035?

By 2035, the US Xerosis Market is projected to reach a value of 3.5 billion USD.

What is the expected CAGR for the US Xerosis Market from 2025 to 2035?

The expected CAGR for the US Xerosis Market from 2025 to 2035 is 7.075%.

Who are the major players in the US Xerosis Market?

Key players in the US Xerosis Market include Novartis, Eucerin, GlaxoSmithKline, and Eli Lilly among others.

What will be the market value for emollients in the US Xerosis Market by 2035?

The market value for emollients in the US Xerosis Market is anticipated to be 1.1 billion USD by 2035.

How much is the moisturizer segment expected to grow by 2035?

The moisturizer segment is expected to grow to 0.85 billion USD by 2035.

What is the projected market size for humidifiers in the US Xerosis Market in 2035?

The projected market size for humidifiers in the US Xerosis Market is estimated to be 0.7 billion USD by 2035.

How much is the oils segment expected to be valued at in 2035 within the US Xerosis Market?

The oils segment is expected to be valued at 0.45 billion USD in 2035.

What is the anticipated market size for 'others' treatment segment by 2035?

The 'others' treatment segment is anticipated to reach a market size of 0.3 billion USD by 2035.

What are the emerging trends driving growth in the US Xerosis Market?

Emerging trends such as increased awareness about skin health and the rising availability of advanced treatment options are driving growth.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions